Targeting ROS1 with anaplastic lymphoma kinase inhibitors: A promising therapeutic strategy for a newly defined molecular subset of non-small-cell lung cancer

Targeting ROS1 with anaplastic lymphoma kinase inhibitors: A promising therapeutic strategy for a newly defined molecular subset of non-small-cell lung cancer

10.1097/JTO.0b013e31826baf83

Saved in:
Bibliographic Details
Main Authors: Chin, L.P., Soo, R.A., Soong, R., Ou, S.-H.I.
Other Authors: CANCER SCIENCE INSTITUTE OF SINGAPORE
Format: Review
Published: 2014
Subjects:
Anaplastic lymphoma kinase inhibitors
Crizotinib
Non-small-cell lung cancer
ROS1
Targeted therapy
Online Access:http://scholarbank.nus.edu.sg/handle/10635/115550
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
Be the first to leave a comment!
You must be logged in first

Similar Items